Harbour Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$575K Buy
479
+11
+2% +$11.2K 0.39% 46
2026
Q1
$431K Buy
468
+15
+3% +$15.2K 0.32% 61
2025
Q4
$487K Buy
+453
New +$433K 0.38% 51

Other funds holding LLY

Harbour Wealth Management Group's LLY Position: Q2 2026 in Review

Harbour Wealth Management Group increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $11.2K and bringing the position to 479 shares worth $575K. The position accounts for 0.39% of the portfolio, ranked #46.

Harbour Wealth Management Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbour Wealth Management Group held 479 shares of Eli Lilly worth $575K as of Q2 2026.
  • Harbour Wealth Management Group bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.39% of Harbour Wealth Management Group's portfolio in Q2 2026, its #46 holding.
  • Harbour Wealth Management Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbour Wealth Management Group's 13F filing for Q2 2026, filed 7 Aug 2026.